| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2024 | 15 May 2024 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited financial results for the year ended March 31 2024 Board of Directors of the Company (Board), at their meeting held on this day, May 29, 2024, inter alia, has considered and approved the following agenda: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2024, together with Auditors Report thereon; 2. Issue and allotment of 28,255 (Twenty-Eight Thousand Two Hundred Fifty Five) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes of the Company. 3. Re-appointment of Ms. Geeta Mathur (DIN: 02139552), as an Independent Director of the Company for a term of three (3) years with effect from June 17, 2024, subject to the approval of shareholders of the Company, and that Ms. Geeta Mathur shall not be liable to retire by rotation. The Company shall make detailed disclosure under Regulation 30 of SEBI LODR Regulations, 2015 in this regard. Pursuant to Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024, together with Auditors Report, as approved by the Board. The financial results are also being made available on the Companys website at www.hcgoncology.com We hereby declare that the Statutory Auditors of the Company, M/s. B S R & Co. LLP, have issued an Audit Report with an unmodified opinion on Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2024. (As Per BSE Announcement Dated on 29.05.2024) | ||
| Board Meeting | 8 Feb 2024 | 17 Jan 2024 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2023 Results - Financial Results for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 08/02/2024) | ||
| Board Meeting | 9 Nov 2023 | 25 Oct 2023 |
| HEALTHCARE GLOBAL ENTERPRISES LIMITED has informed BSE about Board Meeting to be held on 09 Nov 2023 to consider financial statements for the period ended September 2023. Financial results / Other business / ESOP. | ||
| Board Meeting | 18 Aug 2023 | 18 Aug 2023 |
| Mr. Srinivasa V Raghavan, CFO and KMP of the Company, will cease to hold the position as the CFO and KMP effective from August 20, 2023, on account of his retirement from the Company. Appointment of Ms. Ruby Ritolia as CFO and KMP of the Company effective from August 21, 2023. | ||
| Board Meeting | 10 Aug 2023 | 27 Jul 2023 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve and take on record the Unaudited Financial Results for the quarter ended June 30 2023. Further to our intimation dated July 27, 2023, we wish to inform you that, the Board of Directors of the Company (Board), at their meeting held on this day, August 10, 2023, inter alia, has considered and approved the following agenda: 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2023, together with the Limited Review Report thereon; 2. Issue and allotment of 56,550 (Fifty-Six Thousand Five Hundred Fifty) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes of the Company. Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended June 30, 2023, together with Limited Review Report thereon; issue and allotment of 56,550 equity shares of the Company of INR 10 each, upon exercise of Emploiyee Stock Options in accordance with the exisitng ESOP Scheme of the Company (As Per BSE Announcement dated on 10.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
